vs
Side-by-side financial comparison of Cycurion, Inc. (CYCU) and Scilex Holding Co (SCLX). Click either name above to swap in a different company.
Scilex Holding Co is the larger business by last-quarter revenue ($4.8M vs $3.5M, roughly 1.4× Cycurion, Inc.). Cycurion, Inc. runs the higher net margin — -141.2% vs -961.9%, a 820.7% gap on every dollar of revenue. On growth, Cycurion, Inc. posted the faster year-over-year revenue change (-13.1% vs -67.8%). Over the past eight quarters, Cycurion, Inc.'s revenue compounded faster (-8.6% CAGR vs -33.6%).
Scilex Holding Co is a commercial-stage biopharmaceutical firm focused on developing and commercializing innovative non-opioid pain management therapies for acute and chronic pain segments. It primarily serves the US market, offering prescription and over-the-counter pain relief solutions for patients and healthcare providers.
CYCU vs SCLX — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $3.5M | $4.8M |
| Net Profit | $-5.0M | $-46.1M |
| Gross Margin | 12.1% | 45.5% |
| Operating Margin | -141.7% | -2317.8% |
| Net Margin | -141.2% | -961.9% |
| Revenue YoY | -13.1% | -67.8% |
| Net Profit YoY | -546.8% | -613.7% |
| EPS (diluted) | $-11.09 | $-4.63 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $3.5M | $4.8M | ||
| Q3 25 | $3.8M | $10.6M | ||
| Q2 25 | $3.9M | $9.9M | ||
| Q1 25 | $3.9M | $5.0M | ||
| Q4 24 | $4.1M | $14.9M | ||
| Q3 24 | $4.5M | $14.4M | ||
| Q2 24 | $5.0M | $16.4M | ||
| Q1 24 | $4.2M | $10.9M |
| Q4 25 | $-5.0M | $-46.1M | ||
| Q3 25 | $-3.1M | $-257.8M | ||
| Q2 25 | $-5.3M | $-44.0M | ||
| Q1 25 | $-10.2M | $-26.1M | ||
| Q4 24 | $1.1M | $-6.5M | ||
| Q3 24 | $116.1K | $-4.4M | ||
| Q2 24 | $306.1K | $-37.6M | ||
| Q1 24 | $-312.5K | $-24.4M |
| Q4 25 | 12.1% | 45.5% | ||
| Q3 25 | 7.1% | 68.5% | ||
| Q2 25 | 6.1% | 66.9% | ||
| Q1 25 | 17.5% | 72.3% | ||
| Q4 24 | 37.9% | 68.5% | ||
| Q3 24 | 16.1% | 73.9% | ||
| Q2 24 | 20.5% | 73.2% | ||
| Q1 24 | 8.2% | 64.7% |
| Q4 25 | -141.7% | -2317.8% | ||
| Q3 25 | -118.2% | -1766.2% | ||
| Q2 25 | -96.9% | -207.2% | ||
| Q1 25 | -260.9% | -557.5% | ||
| Q4 24 | 31.9% | -190.5% | ||
| Q3 24 | 9.4% | -138.0% | ||
| Q2 24 | 14.6% | -95.4% | ||
| Q1 24 | -0.8% | -179.0% |
| Q4 25 | -141.2% | -961.9% | ||
| Q3 25 | -81.5% | -2441.5% | ||
| Q2 25 | -136.1% | -445.1% | ||
| Q1 25 | -264.8% | -521.2% | ||
| Q4 24 | 27.5% | -43.4% | ||
| Q3 24 | 2.6% | -30.4% | ||
| Q2 24 | 6.1% | -229.6% | ||
| Q1 24 | -7.4% | -224.0% |
| Q4 25 | $-11.09 | $-4.63 | ||
| Q3 25 | $-1.59 | $-22.17 | ||
| Q2 25 | $-0.15 | $-7.42 | ||
| Q1 25 | $-0.56 | $-2.26 | ||
| Q4 24 | $1.56 | $8.53 | ||
| Q3 24 | $0.11 | $-0.58 | ||
| Q2 24 | $0.01 | $-7.67 | ||
| Q1 24 | $-0.02 | $-8.33 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $5.3M | $5.0M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $20.1M | $-207.8M |
| Total Assets | $33.5M | $365.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $5.3M | $5.0M | ||
| Q3 25 | $3.7M | $878.0K | ||
| Q2 25 | $1.0M | $4.1M | ||
| Q1 25 | — | $5.8M | ||
| Q4 24 | $38.7K | $3.3M | ||
| Q3 24 | — | $77.0K | ||
| Q2 24 | — | $6.9M | ||
| Q1 24 | — | $1.8M |
| Q4 25 | $20.1M | $-207.8M | ||
| Q3 25 | $19.1M | $-176.9M | ||
| Q2 25 | $14.0M | $-249.0M | ||
| Q1 25 | $12.9M | $-211.5M | ||
| Q4 24 | $3.5M | $-192.6M | ||
| Q3 24 | $-3.7M | $-211.3M | ||
| Q2 24 | $-3.4M | $-214.7M | ||
| Q1 24 | $-2.8M | $-189.8M |
| Q4 25 | $33.5M | $365.0M | ||
| Q3 25 | $32.3M | $275.9M | ||
| Q2 25 | $30.7M | $83.8M | ||
| Q1 25 | $31.5M | $79.0M | ||
| Q4 24 | $25.6M | $93.0M | ||
| Q3 24 | $2.9M | $100.4M | ||
| Q2 24 | $2.7M | $104.5M | ||
| Q1 24 | $3.1M | $91.2M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-3.3M | $-17.5M |
| Free Cash FlowOCF − Capex | $-3.5M | — |
| FCF MarginFCF / Revenue | -98.8% | — |
| Capex IntensityCapex / Revenue | 5.3% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-12.5M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-3.3M | $-17.5M | ||
| Q3 25 | $-2.5M | $8.2M | ||
| Q2 25 | $-3.6M | $7.0M | ||
| Q1 25 | $-2.7M | $6.0M | ||
| Q4 24 | $-205.7K | $2.5M | ||
| Q3 24 | $-315.2K | $5.1M | ||
| Q2 24 | $-578.0K | $2.3M | ||
| Q1 24 | $-272.4K | $9.4M |
| Q4 25 | $-3.5M | — | ||
| Q3 25 | $-2.6M | — | ||
| Q2 25 | $-3.7M | — | ||
| Q1 25 | $-2.8M | — | ||
| Q4 24 | $-310.7K | — | ||
| Q3 24 | $-420.2K | — | ||
| Q2 24 | $-711.0K | — | ||
| Q1 24 | $-377.4K | — |
| Q4 25 | -98.8% | — | ||
| Q3 25 | -66.9% | — | ||
| Q2 25 | -94.2% | — | ||
| Q1 25 | -72.7% | — | ||
| Q4 24 | -7.6% | — | ||
| Q3 24 | -9.4% | — | ||
| Q2 24 | -14.2% | — | ||
| Q1 24 | -8.9% | — |
| Q4 25 | 5.3% | — | ||
| Q3 25 | 2.5% | — | ||
| Q2 25 | 2.7% | — | ||
| Q1 25 | 1.8% | — | ||
| Q4 24 | 2.6% | — | ||
| Q3 24 | 2.4% | 0.0% | ||
| Q2 24 | 2.7% | — | ||
| Q1 24 | 2.5% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -0.18× | — | ||
| Q3 24 | -2.71× | — | ||
| Q2 24 | -1.89× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
